Pharmaceutical company Mallinckrodt expects to pay $15 million to settle DOJ drug bribing probe

Business

HP Acthar made by Mallinckrodt Pharmaceuticals is an anti-inflamatory medicine used by multiple sclerosis patients.

Source: Mallinckrodt Pharmaceuticals

Pharmaceutical company Mallinckrodt said Wednesday it reached a tentative deal with the U.S. Justice Department to settle a drug bribery probe into Questcor Pharmaceuticals, which it acquired in 2014. 

This story is developing. Check back for updates. 

Products You May Like

Articles You May Like

How investors can stay protected with emerging market opportunities
Student loan forgiveness deadline is June 30. Here’s what borrowers need to know
China has spent at least $230 billion to build its EV industry, new study finds
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
A lack of estate planning contributes to the racial wealth gap in homeownership. How JPMorgan is stepping in to help

Leave a Reply

Your email address will not be published. Required fields are marked *